课题基金 / 基金详情

HIV-1 gp120-induced Endothelial Cell Dysfunction

HIV-1 gp120-induced Endothelial Cell Dysfunction
HIV-1 gp120 诱导的内皮细胞功能障碍
批准号:
7213429
负责人:
GEORGETTE D. KANMOGNE
金额:
$10.64万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31

项目摘要

项目成果

GEORGETTE D. KANMOGNE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):人类免疫缺陷病毒(HIV)在感染的早期阶段入侵大脑对于感染晚期的患者来说,中枢神经系统(CNS)功能障碍是常见的致病原因,经常导致进行性痴呆、脑萎缩和死亡。有证据表明,HIV和/或HIV相关蛋白在HIV相关性痴呆(HAD)复合体的发病机制中起关键作用。要阐明HAD的发病机制,了解HIV侵袭大脑的机制是重要的。血脑屏障的破坏在HAD患者中很常见,尽管缺乏有效的HIV感染脑血管内皮细胞。HIV-1包膜蛋白gp120存在于HIV脑炎患者的大脑中,是神经毒性的最新证据,来自我们实验室和其他人的证据表明,gp120对脑内皮细胞有直接影响。我们的假设是gp120直接导致血脑屏障功能障碍,并在病毒侵袭脑中发挥重要作用。为了验证这一假说,我们计划实现以下目标。目的:为了验证HIV-1gp120蛋白对人脑微血管内皮细胞的毒性并直接诱导血脑屏障的破坏和/或破坏的假说,我们将检测内皮细胞的通透性和凋亡率。目的2为了验证gp120蛋白暴露于人脑微血管内皮细胞导致紧密连接蛋白丢失的假说,我们将用免疫印迹和免疫荧光方法检测occludin、Claudia-5和zonula occludens-1的表达。目的3:确定趋化因子受体是否参与gp120诱导的血脑屏障的破坏和/或损伤。目的4:确定gp120诱导的血脑屏障功能障碍的信号转导途径。这些实验的数据将有助于确定gp120在破坏血脑屏障完整性和艾滋病毒入侵大脑中所起的作用,并将提出预防艾滋病毒感染期间gp120介导的脑内皮功能障碍的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): The human immunodeficiency virus (HIV) invades the brain in the early stages of infection For patients in the advanced stage of infection, dysfunction of the central nervous system (CNS) is a common cause of morbidity and often leads to progressive dementia, cerebral atrophy and death. Evidence suggest that HIV and /or HIV-associated proteins are critical to the pathogenesis of the HIV-associated dementia (HAD)complex .To elucidate the pathogenesis of HAD, it is important to understand by what mechanisms HIV invades the brain. Breakdown of the blood-brain barrier is commonly seen in patients with HAD, despite the lack of productive HIV-infection of the brain endothelium. The HIV-1 envelope protein gp120 is present in the brain of patients with HIV encephalitis, and is neurotoxic Recent evidence from our laboratory, and by others, suggests a direct effect of gp120 on the brain endothelium. It is our hypothesis that gp120 directly causes blood-brain barrier dysfunction and plays a major role in viral invasion of the brain To test this hypothesis, we plan the following aims. Aim 1: To test the hypothesis that HIV-1 gp120 proteins are toxic to human brain microvascular endothelial cells and directly induce a disruption and/or damage of the blood-brain barrier we will measure endothelial cell permeability and apoptosis. Aim 2 To test the hypothesis that exposure of gp120 proteins to human brain microvascular endothelial cells result in the loss of tight junction proteins we will assess the expression of occludin, claudia-5 and zonula occludens-1 using western blotting and immunofluorescence. Aim 3: To determine if chemokine receptors are involved in gp120-induced blood-brain barrier disruption and/or damage Aim 4: To determine the signal transduction pathways involved in gp120-induced blood-brain barrier dysfunction. Data from these experiments will help determine the role that gp120 plays in the breach of blood-brain barrier integrity and HIV invasion of the brain, and will suggest therapeutic approaches to preventing gp120-mediated dysfunction of the brain endothelium during HIV infection.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.mvr.2008.11.003
发表时间: 2009-03
期刊: MICROVASCULAR RESEARCH
影响因子: 3.1
作者: [Yang, Bo, Akhter, Sidra, Chaudhuri, Anathbandhu, Kanmogne, Georgette D.]
通讯作者: Kanmogne, Georgette D.
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
HIV Genetic Diversity and Viral Neuropathogenesis
海外基金